Patheon Overview
- Year Founded
-
1990
- Status
-
Acquired/Merged
- Employees
-
12,000
- Latest Deal Type
-
M&A
- Financing Rounds
-
15
- Investments
-
5
Patheon General Information
Description
Provider of contract development and manufacturing services intended for the pharmaceutical and biotechnology industries. The company offers active pharmaceutical ingredients, biologics, cell and gene therapies, oral solid-doses, sterile injectables, softgels, clinical trial supplies, secondary packaging services, logistics and distribution, and plasmid DNA manufacturing, enabling drug developers to accelerate therapy commercialization through integrated global facilities and technical expertise.
Contact Information
Website
www.patheon.com(Operating Subsidiary)
Corporate Office
- 168 Third Avenue Waltham
- Waltham, MA 02451
- United States
Corporate Office
- 168 Third Avenue Waltham
- Waltham, MA 02451
- United States
Patheon Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Patheon Comparisons
Industry
Financing
Details
Patheon Competitors (27)
One of Patheon’s 27 competitors is Cambrex, a Private Equity-Backed company based in East Rutherford, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cambrex | Private Equity-Backed | East Rutherford, NJ | ||||
| Catalent | Private Equity-Backed | Tampa, FL | ||||
| Bend Bioscience (Formerly CoreRx) | Private Equity-Backed | Clearwater, FL | ||||
| Hovione | Private Equity-Backed | Baar, Switzerland | ||||
| Recipharm | Private Equity-Backed | Stockholm, Sweden |
Patheon Patents
Patheon Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026206934-A1 | Chewable soft gelatin capsule formulation | Pending | 24-Mar-2025 | ||
| WO-2026076393-A2 | Lecithin-free cold and cough formulation | Pending | 04-Oct-2024 | ||
| WO-2026076393-A3 | Lecithin-free cold and cough formulation | Pending | 04-Oct-2024 | ||
| WO-2026050391-A1 | Naproxen formuation | Pending | 28-Aug-2024 | ||
| EP-4832876-A1 | Precipitation inhibitor softgel formulations | Pending | 28-Dec-2023 | A61K9/4825 |
Patheon Signals
Patheon Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Patheon Investments & Acquisitions (5)
Patheon’s most recent deal was a Buyout/LBO with Gallus Biopharmaceuticals for . The deal was made on 30-Sep-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Gallus Biopharmaceuticals | 30-Sep-2014 | Buyout/LBO | Biotechnology | ||
| DSM Pharmaceutical Products | 11-Mar-2014 | Buyout/LBO | Pharmaceuticals | ||
| Banner Life Sciences | 14-Dec-2012 | Buyout/LBO | Drug Discovery | ||
| MOVA Pharmaceutical | 23-Dec-2004 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Global Pharm | 30-Aug-2000 | Merger/Acquisition | Pharmaceuticals |
Patheon Exits (1)
Patheon’s most recent exit was on 14-Dec-2012 from Banner Life Sciences. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Banner Life Sciences | 14-Dec-2012 | Completed |
|
Patheon FAQs
-
When was Patheon founded?
Patheon was founded in 1990.
-
Where is Patheon headquartered?
Patheon is headquartered in Waltham, MA.
-
What is the size of Patheon?
Patheon has 12,000 total employees.
-
What industry is Patheon in?
Patheon’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Patheon a private or public company?
Patheon is a Private company.
-
What is the current valuation of Patheon?
The current valuation of Patheon is .
-
What is Patheon’s current revenue?
The current revenue for Patheon is .
-
How much funding has Patheon raised over time?
Patheon has raised $981M.
-
Who are Patheon’s investors?
Advent-Morro Equity Partners, DSM-Firmenich, Foresite Capital, and JLL Partners have invested in Patheon.
-
Who are Patheon’s competitors?
Cambrex, Catalent, Bend Bioscience (Formerly CoreRx), Hovione, and Recipharm are some of the 27 competitors of Patheon.
-
When was Patheon acquired?
Patheon was acquired on 29-Aug-2017.
-
Who acquired Patheon?
Patheon was acquired by Thermo Fisher Scientific.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process